Full-Time

Histology Supervisor

Posted on 11/18/2024

Veracyte

Veracyte

501-1,000 employees

Develops genomic tests for cancer diagnosis

Biotechnology
Healthcare

Compensation Overview

$95k - $108kAnnually

+ Bonus + Incentives + Restricted Stock Units

Senior

San Diego, CA, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s or Associate’s degree in science
  • Certification: HT (ASCP) or HTL (ASCP)
  • At least 7 years of experience as a histotechnician or histotechnologist sectioning paraffin-embedded tissues, with at least 2 years of supervising histology operations and people management
  • Ability to confidently and rapidly cut and mount high quality tissue sections from a variety of tissue types including needle biopsies
  • Maintains continuing education units required by California Department of Health Services
  • Must be meticulous and detail oriented
  • Demonstrated experience implementing process improvements and updating standard operating procedures
  • Experience training and onboarding new team members
  • Prior experience implementing digital pathology workflows is a plus
Responsibilities
  • Provide orientation and training to all histology personnel
  • Evaluate and document the competency of all histology personnel
  • Extensive SOP drafting experience, to include all aspects of standard histopathology
  • Essential member of cross-functional team to provide user requirements and develop IT infrastructure to establish internal histology services from the ground-up
  • Working under general direction to precisely and accurately conduct a variety of routine and specialized histology procedures. Researching, troubleshooting, and resolving histology related inquiries and problems within the laboratory. This position requires you to produce the highest quality of microtomy, tissue grossing, tissue processing, and H&E staining, and equipment maintenance
  • Preparing microscopic slides on human tissue for research/diagnostic purposes, including processing, embedding, microtomy, and mounting to include paraffin processed tissue
  • Slide organization, prepares and maintains all necessary reagents, including stains, alcohols, and paraffins according to proper specifications
  • Handling and disposing of hazardous materials
  • Performing routine and non-routine activities involved in the preparation of slides for microscopic evaluation by a pathologist(s) according to established SOP’s
  • Specimen management including return of blocks/slides to client pathology labs and organization of slides retained to meet regulatory requirements

Veracyte specializes in cancer diagnostics by developing advanced genomic tests that assist in the early detection and diagnosis of various cancers. Their tests analyze genetic information from non-invasive samples, such as nasal swabs or tissue biopsies, providing crucial insights into the presence and progression of cancer. This allows healthcare providers, including hospitals and clinics, to make informed treatment decisions tailored to individual patients. Veracyte differentiates itself from competitors by focusing on non-invasive testing methods and continuously investing in research to expand its product offerings. The company's goal is to improve patient outcomes and enhance the efficiency of cancer treatment through accurate and early diagnosis.

Company Stage

IPO

Total Funding

$69.4M

Headquarters

San Francisco, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

5%

1 year growth

7%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recognition as a Bay Area Top Workplace for 11 consecutive years highlights a positive work environment and strong company culture.
  • Significant investments from firms like Aigen Investment Management and Quest Partners indicate strong financial backing and growth potential.
  • The upcoming launch of ClearLab and an MRD assay in 2026 showcases Veracyte's commitment to expanding its product portfolio and market reach.

What critics are saying

  • The competitive landscape in genomic diagnostics is intense, requiring Veracyte to continuously innovate to maintain its market position.
  • Dependence on successful clinical validation and regulatory approval for new tests can pose risks to product launch timelines.

What makes Veracyte unique

  • Veracyte specializes in non-invasive genomic tests for early cancer detection, setting it apart from traditional diagnostic methods.
  • Their Decipher Prostate and Bladder Genomic Classifiers offer superior prognostic information compared to standard approaches, enhancing treatment personalization.
  • Continuous investment in R&D and clinical validation ensures that Veracyte's tests remain at the forefront of cancer diagnostics.

Help us improve and share your feedback! Did you find this helpful?